Combining an HIV vaccine with immunotherapy may reduce the need for daily medication

People with HIV need to take daily medication to keep the virus at bay. A study has found that a new treatment combination could boost immunity and control virus levels even after stopping medication.

Rama Rao Amara, Professor of Microbology and Immunology, Emory University • conversation
Sept. 29, 2021 ~6 min

Spreading HIV, the virus that causes AIDS, is against the law in 37 states – with penalties ranging up to life in prison

Current HIV criminal laws increase HIV stigma and discrimination against marginalized people – and negatively affect public health.

Robin Lennon-Dearing, Associate Professor of Social Work, University of Memphis • conversation
Sept. 22, 2021 ~8 min


App-based self-test program improves HIV detection

An app-based HIV self-test program linked participants to counseling services and care, detected new infections, and increased referrals to self-test.

Fabienne Landry-McGill • futurity
Sept. 3, 2021 ~5 min

People living with HIV face harmful stigma daily – DaBaby's rant was just more public than most

Microaggressions are more subtle than outright discrimination. But they can directly affect HIV treatment outcomes.

Sannisha Dale, Associate Professor of Psychology, University of Miami • conversation
Aug. 9, 2021 ~7 min

New flu shot gets power from billions of protein-carrying sacs

A new experimental nanoparticle-based vaccine that has proven effective for flu, is also being tested for COVID-19 and studied as an HIV vaccine.

Cory Nealon-Buffalo • futurity
May 26, 2021 ~7 min

HIV/AIDS vaccine: Why don't we have one after 37 years, when we have several for COVID-19 after a few months?

Scientists developed vaccines for COVID-19 in a matter of months. Why after 37 years do we still not have one for HIV/AIDS? On HIV Vaccine Awareness Day, it's an important question to ask.

Ronald C. Desrosiers, Professor of Pathology, Vice-chair for Research, University of Miami • conversation
May 17, 2021 ~10 min

At-risk people know PrEP prevents HIV but few take it

People at high risk for HIV know about pre-exposure prophylaxis (PrEP) to prevent HIV infection, but few take it, a study finds.

Patti Verbanas-Rutgers • futurity
April 23, 2021 ~4 min

Using AI to reduce the risk of HIV

Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences have developed an AI system that can identify the people within a social network who can most effectively promote information about HIV prevention to their peers.

Leah Burrows • harvard
Feb. 19, 2021 ~6 min


FDA Approves First Long-Acting HIV Drug Combo

VOA Learning English • voa
Jan. 25, 2021 ~4 min

Can gene editing tech eliminate hard-to-reach HIV?

Researchers have used gene editing technology to prevent the replication of a virus that's similar to HIV. It could be a step towards the end of the virus.

Leslie Tate-Tulane • futurity
Dec. 7, 2020 ~4 min

/

10